General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 1101: Extracellular hyaline change is seen in:

A. Arteriosclerosis (Correct Answer)
B. Chronic glomerulonephritis
C. Leiomyoma
D. Alcoholic hyaline

Explanation: **Explanation:** **Hyaline change** refers to an intra- or extracellular alteration that gives a homogeneous, glassy, pink appearance in routine H&E sections [3]. It is a descriptive histological term rather than a specific marker of a single disease. **1. Why Arteriosclerosis is correct:** In **Hyaline Arteriosclerosis** (commonly seen in benign hypertension and diabetes mellitus), there is an **extracellular** accumulation of plasma proteins that leak across injured endothelial cells into the vessel wall [1]. This is coupled with increased smooth muscle cell matrix synthesis, leading to the characteristic thickened, glassy pink appearance of the arteriolar wall [2]. **2. Analysis of Incorrect Options:** * **Chronic Glomerulonephritis:** While "hyalinization" of glomeruli occurs, it is technically a result of fibrous tissue replacement (collagen deposition) rather than simple proteinaceous hyaline change [3]. * **Leiomyoma:** These tumors often undergo "hyaline degeneration" as they outgrow their blood supply. However, this is a degenerative change of the connective tissue/stroma, and in the context of standard pathology exams, **Arteriosclerosis** is the classic, textbook example of extracellular hyaline change. * **Alcoholic Hyaline (Mallory-Denk bodies):** This is a classic example of **intracellular** hyaline change. It consists of eosinophilic cytoplasmic inclusions of pre-keratin intermediate filaments within hepatocytes. **3. NEET-PG High-Yield Pearls:** * **Intracellular Hyaline Examples:** Mallory bodies (Alcoholic liver disease), Russell bodies (Plasma cells), Councilman bodies (Apoptotic hepatocytes in Yellow fever/Viral hepatitis), and Proximal tubular droplets (Proteinuria). * **Extracellular Hyaline Examples:** Hyaline arteriosclerosis [2], Hyaline membrane disease (RDS in neonates), and Old scars/Keloids. * **Staining:** Hyaline change is non-specific, but if it is amyloid (a type of extracellular hyaline), it will stain with Congo Red [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 498-499. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 943-945. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 907-908. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266.

Question 1102: Which of the following is not a hereditary disease?

A. Neurofibromatosis
B. Cretinism (Correct Answer)
C. Huntington's disease
D. Hereditary spherocytosis

Explanation: **Explanation:** The distinction between **hereditary** and **congenital** diseases is a high-yield concept in General Pathology [2]. A hereditary disease is derived from one’s parents and transmitted through the germline (genetic), whereas a congenital disease is simply "present at birth" [2]. **Why Cretinism is the correct answer:** Cretinism (Congenital Hypothyroidism) is primarily an **acquired or developmental condition**, not a hereditary one [1]. The most common cause worldwide is **maternal iodine deficiency** during pregnancy [1]. Other causes include thyroid dysgenesis (developmental defect) or enzyme defects blocking hormone synthesis [1]. While rare "dyshormonogenetic" forms exist, the condition itself is classified as a congenital metabolic syndrome rather than a classic hereditary disorder transmitted via Mendelian inheritance. **Analysis of Incorrect Options:** * **Neurofibromatosis (Type 1 & 2):** These are **Autosomal Dominant** disorders. NF1 is caused by a mutation in the *NF1* gene on chromosome 17, and NF2 on chromosome 22. * **Huntington’s Disease:** A classic **Autosomal Dominant** neurodegenerative disorder characterized by **CAG trinucleotide repeats** in the *HTT* gene on chromosome 4 [2]. * **Hereditary Spherocytosis:** The most common hereditary hemolytic anemia in Caucasians, usually inherited in an **Autosomal Dominant** pattern (defects in Ankyrin, Spectrin, or Band 3). **NEET-PG High-Yield Pearls:** 1. **Congenital vs. Hereditary:** All hereditary diseases are genetic, but not all congenital diseases are hereditary (e.g., Congenital Syphilis, Fetal Alcohol Syndrome) [2]. 2. **Iodine Deficiency:** Still the most common cause of preventable intellectual disability (Cretinism) globally [1]. 3. **Screening:** Neonatal screening for TSH is mandatory in many regions to prevent the irreversible neurological damage associated with Cretinism [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 426-427. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 148-149.

Question 1103: All of the following events occur during mitosis except:

A. Cytokinesis
B. Chromatids separate
C. DNA replication (Correct Answer)
D. The kinetochore becomes evident

Explanation: **Explanation:** The cell cycle is divided into two main phases: **Interphase** (the preparatory phase) and **M-phase** (Mitosis). **Why DNA replication is the correct answer:** DNA replication occurs exclusively during the **S-phase (Synthesis phase)** of Interphase, not during Mitosis [1]. During this stage, the DNA content doubles (2n to 4n) to ensure that each daughter cell receives an identical set of chromosomes [1]. By the time a cell enters Mitosis (Prophase), DNA replication is already complete. **Analysis of incorrect options:** * **Cytokinesis (Option A):** This is the final step of the M-phase, where the cytoplasm divides to form two distinct daughter cells. It usually begins during late anaphase or telophase. * **Chromatids separate (Option B):** This is the hallmark of **Anaphase**. The centromeres split, and sister chromatids are pulled toward opposite poles of the cell. * **The kinetochore becomes evident (Option D):** Kinetochores are protein structures assembled on the centromeres. They become visible and functional during **Prometaphase** (a sub-stage of Mitosis) to allow spindle fibers to attach to the chromosomes. **High-Yield Clinical Pearls for NEET-PG:** * **G1 Phase:** The most variable phase in terms of duration [2]. Cells that stop dividing enter the **G0 (Quiescent) phase** [2]. * **Checkpoints:** The **G1-S checkpoint** (regulated by p53 and Rb protein) is the most critical "restriction point" in the cell cycle [3]. * **Mitotic Inhibitors:** Drugs like **Vincristine/Vinblastine** act on the M-phase by inhibiting microtubule formation, while **Paclitaxel** acts by stabilizing microtubules [2]. * **Lab Fact:** The "Mitotic Index" is used in histopathology to grade the aggressiveness of tumors (e.g., Breast Cancer). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 78-79. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 79-80. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 302-303.

Question 1104: Which HLA marker is associated with Behcet's syndrome?

A. HLA-B27
B. HLA-DR5
C. HLA-B51 (Correct Answer)
D. HLA-CW6

Explanation: ### Explanation **Correct Answer: C. HLA-B51** **Why it is correct:** Behcet’s syndrome is a chronic, multi-systemic inflammatory disorder characterized by the triad of **recurrent oral ulcers, genital ulcers, and uveitis**. The strongest genetic risk factor identified for this condition is the **HLA-B51** allele (a subtype of HLA-B5). While the exact pathogenesis is unknown, it is believed that HLA-B51 contributes to neutrophil hyperreactivity and an exaggerated inflammatory response, particularly in populations along the "Silk Road" (Middle East and East Asia). **Analysis of Incorrect Options:** * **A. HLA-B27:** Classically associated with **Seronegative Spondyloarthropathies**, including Ankylosing Spondylitis [1], Reiter’s syndrome (Reactive Arthritis), Psoriatic arthritis, and Enteropathic arthritis. * **B. HLA-DR5:** Associated with **Hashimoto’s thyroiditis** and sometimes linked to Pernicious anemia and Juvenile Rheumatoid Arthritis. * **D. HLA-CW6:** This is the primary genetic marker associated with **Psoriasis vulgaris**, specifically early-onset (Type I) psoriasis. **High-Yield Clinical Pearls for NEET-PG:** * **Pathergy Test:** A unique diagnostic feature of Behcet’s where a sterile skin papule or pustule forms 24–48 hours after a needle prick. * **Vascular Involvement:** Behcet’s is unique among vasculitides as it can involve vessels of **all sizes** (small, medium, and large) on both the **arterial and venous** sides (e.g., Budd-Chiari syndrome). * **Hypopyon:** The uveitis in Behcet’s often presents with a "sterile hypopyon" (pus in the anterior chamber of the eye). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 49-50.

Question 1105: What is the primary purpose of sentinel lymph node biopsy in carcinoma of the breast?

A. Early diagnosis of cancer
B. Staging the tumors (Correct Answer)
C. Frozen section analysis
D. Detection of occult disease

Explanation: **Explanation:** The **Sentinel Lymph Node (SLN)** is defined as the first lymph node(s) in a regional lymphatic basin that receives direct drainage from a primary tumor [1]. In breast cancer, the status of the axillary lymph nodes is the **most important prognostic factor** [1]. **Why "Staging the tumors" is correct:** The primary purpose of SLN biopsy (SLNB) is to determine if the cancer has spread to the regional lymphatics. Under the **TNM Staging System**, the presence or absence of nodal metastasis determines the **'N' (Nodal) stage** [2], [3]. If the SLN is negative for malignancy, it is highly likely (95-98% accuracy) that the remaining axillary nodes are also negative, allowing the patient to avoid a morbid Axillary Lymph Node Dissection (ALND) [1]. **Analysis of Incorrect Options:** * **A. Early diagnosis of cancer:** Diagnosis is confirmed via Triple Assessment (Clinical exam, Imaging, and Core Needle Biopsy). SLNB is performed only *after* a diagnosis of invasive cancer is established. * **C. Frozen section analysis:** This is a *method* used intraoperatively to examine the node, not the *purpose* of the biopsy itself. * **D. Detection of occult disease:** While SLNB can find micrometastases, its clinical utility is defined by its role in regional staging and surgical planning. **High-Yield Facts for NEET-PG:** * **Technique:** Usually performed using a combination of **Technetium-99m labeled sulfur colloid** (radioactive tracer) and **Isosulfan/Methylene blue dye** [1]. * **Indication:** Clinically node-negative (cN0) early-stage breast cancer. * **Skip Metastasis:** When a non-sentinel node is positive while the SLN is negative (rare in breast cancer, approx. 1-3%). * **Contraindications:** Inflammatory breast cancer, clinically palpable axillary nodes (cN1+). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1070-1072. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, p. 1072. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 236-237.

Question 1106: The retinoblastoma gene regulates which cell cycle phase transition?

A. G1-S phase (Correct Answer)
B. G2-M phase
C. G0-S phase
D. S-G2 phase

Explanation: The **Retinoblastoma (RB) gene**, located on chromosome **13q14**, is a critical tumor suppressor gene that acts as the "governor" of the cell cycle [1]. ### Why G1-S phase is correct: The RB protein controls the **G1 to S phase transition**, which is the primary checkpoint for cell division [1]. * **Hypophosphorylated (Active) State:** In its active form, RB binds to and sequesters the **E2F transcription factor** [1]. This prevents the transcription of genes (like Cyclin E) required for the S-phase, effectively "braking" the cell cycle. * **Hyperphosphorylated (Inactive) State:** When the cell receives growth signals, Cyclin D-CDK4/6 complexes phosphorylate RB [1]. This causes RB to release E2F, allowing the cell to cross the **restriction point (R point)** and enter the S-phase. ### Why other options are incorrect: * **G2-M phase:** This transition is primarily regulated by **Cyclin B-CDK1** (Mitosis Promoting Factor) and DNA damage sensors like p53, not the RB protein [2]. * **G0-S phase:** Cells in G0 (quiescence) must first enter G1 before proceeding to S. RB specifically regulates the exit from G1 into S. * **S-G2 phase:** This transition involves ensuring DNA replication is complete; it is not the primary site of RB protein activity. ### NEET-PG High-Yield Pearls: * **Knudson’s "Two-Hit" Hypothesis:** Both alleles of the RB gene must be inactivated for tumor development [1]. * **Associated Tumors:** Mutations are linked to Retinoblastoma (familial and sporadic) and **Osteosarcoma**. * **Viral Interaction:** The **E7 protein** of High-risk HPV (16, 18) binds to and inactivates RB, leading to uncontrolled cell proliferation in cervical cancer [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 301-302. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 302-303.

Question 1107: Metastatic calcifications are typically seen in which of the following conditions?

A. Hypoparathyroidism
B. Vitamin D deficiency
C. Hypercalcemia (Correct Answer)
D. All the above

Explanation: Explanation: Pathologic calcification is divided into two types: **Dystrophic** and **Metastatic**. [1] **1. Why Hypercalcemia is Correct:** Metastatic calcification occurs in **normal tissues** whenever there is **hypercalcemia** (elevated serum calcium levels). [1], [2] The underlying mechanism is not local tissue injury, but rather a systemic metabolic derangement. High levels of calcium and phosphate in the blood exceed their solubility product, leading to deposition in various tissues, particularly those with an alkaline internal environment (e.g., gastric mucosa, kidneys, lungs, and systemic arteries). [3] **2. Why the other options are incorrect:** * **Hypoparathyroidism:** This condition leads to *hypocalcemia* (low serum calcium). Metastatic calcification requires an excess of serum calcium; therefore, low levels would not trigger this process. * **Vitamin D deficiency:** Vitamin D is essential for calcium absorption. Its deficiency leads to *hypocalcemia* (and conditions like Rickets or Osteomalacia), which is the opposite of the environment required for metastatic calcification. In contrast, **Vitamin D intoxication** is a known cause of metastatic calcification. [2] **NEET-PG High-Yield Pearls:** * **Common Causes of Metastatic Calcification:** Hyperparathyroidism (most common), bone resorption (multiple myeloma, bony metastasis), Vitamin D intoxication, and Chronic Renal Failure (due to secondary hyperparathyroidism). [1], [2] * **Dystrophic Calcification:** Occurs in **dead or dying tissues** (e.g., areas of necrosis, atheromas, damaged heart valves) with **normal** serum calcium levels. [1] * **Preferred Sites:** Metastatic calcification favors organs that excrete acid (creating a local basic pH), such as the **interstitial tissue of gastric mucosa, kidneys, and lungs.** [3] * **Morphology:** On H&E stain, both types appear as intracellular or extracellular **basophilic** (blue-purple), amorphous granular clumps. [3] **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 134-135. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 127-128. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 76-77.

Question 1108: Quiescent cells belong to which phase of the cell cycle?

A. G1
B. G0 (Correct Answer)
C. M
D. S

Explanation: **Explanation:** The cell cycle is divided into phases of growth and division. Cells are categorized into three groups based on their proliferative capacity: Labile, Stable (Quiescent), and Permanent cells [1]. **Why G0 is Correct:** **Quiescent cells** (Stable cells) are those that have exited the cell cycle and entered a state of dormancy known as the **G0 phase** [1]. In this phase, cells are metabolically active but are not actively dividing. However, they retain the capacity to re-enter the cell cycle (at the G1 phase) in response to specific stimuli, such as growth factors or tissue injury (e.g., hepatocytes after a partial hepatectomy) [1]. **Why other options are incorrect:** * **G1 (Gap 1):** This is the pre-synthetic phase where the cell prepares for DNA replication. Cells in G1 are committed to the cycle, unlike quiescent cells which are outside it [1]. * **S (Synthesis):** This is the phase where DNA replication occurs. * **M (Mitosis):** This is the phase of actual nuclear and cytoplasmic division. **High-Yield Clinical Pearls for NEET-PG:** 1. **Examples of Quiescent (Stable) Cells:** Hepatocytes, proximal renal tubular cells, and mesenchymal cells (fibroblasts, smooth muscle) [1]. 2. **Labile Cells:** These are always in the cell cycle (e.g., hematopoietic cells in bone marrow, surface epithelia of the GI tract and skin) [1]. 3. **Permanent Cells:** These have permanently exited the cell cycle and cannot undergo division (e.g., Neurons, Cardiac myocytes, Skeletal muscle) [1]. 4. **Restriction Point:** The transition from G1 to S is the most critical checkpoint in the cell cycle, regulated primarily by Cyclin D and CDK4/6 [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 37-38.

Question 1109: A cyst arising from the rests of Malassez is:

A. Dental cyst
B. Dentigerous cyst
C. Radicular cyst (Correct Answer)
D. Keratocyst

Explanation: **Explanation:** The **Radicular cyst** (also known as a Periapical cyst) is the most common inflammatory odontogenic cyst. It arises from the **epithelial rests of Malassez**, which are remnants of Hertwig’s epithelial root sheath (HERS) located in the periodontal ligament [1]. When a tooth becomes non-vital due to caries or trauma, the resulting inflammation (periapical granuloma) stimulates these dormant epithelial rests to proliferate, eventually leading to cyst formation [1]. **Analysis of Options:** * **Dentigerous Cyst:** This is a developmental cyst that originates from the **reduced enamel epithelium** (REE). It typically surrounds the crown of an unerupted tooth (most commonly the mandibular 3rd molar) and attaches at the cementoenamel junction. * **Dental Cyst:** This is a general, non-specific term often used interchangeably with radicular cysts in older literature, but in a competitive exam context, "Radicular cyst" is the precise pathological diagnosis for rests of Malassez origin. * **Keratocyst (Odontogenic Keratocyst/OKC):** This arises from the **dental lamina** (rests of Serres). It is known for its aggressive behavior, high recurrence rate, and association with Gorlin-Goltz syndrome. **NEET-PG High-Yield Pearls:** * **Rests of Malassez:** Associated with Radicular cysts (Inflammatory). * **Rests of Serres (Dental Lamina):** Associated with OKC and Ameloblastoma (Developmental/Neoplastic). * **Reduced Enamel Epithelium:** Associated with Dentigerous cysts. * **Rushton bodies:** Eosinophilic, linear, or curved structures found in the epithelial lining of radicular cysts (highly characteristic). * **Radiology:** Radicular cysts appear as well-defined unilocular radiolucencies at the apex of a **non-vital** tooth. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, pp. 741-742.

Question 1110: S100 is a marker used in the diagnosis of which of the following conditions?

A. Melanoma
B. Schwannoma
C. Langerhans cell histiocytosis (LCH)
D. All of the above (Correct Answer)

Explanation: **Explanation:** **S100** is a low-molecular-weight calcium-binding protein originally isolated from the brain. In immunohistochemistry (IHC), it is considered a **highly sensitive but non-specific marker** because it is expressed by a wide variety of cells derived from the neural crest, as well as certain mesenchymal and epithelial cells. **Why "All of the above" is correct:** 1. **Melanoma:** S100 is the most sensitive marker for melanocytic tumors. While markers like HMB-45 and Melan-A are more specific, S100 is almost always positive in both primary and metastatic melanoma. 2. **Schwannoma:** Since S100 is strongly expressed in Schwann cells (neural crest origin), it is the gold standard marker for nerve sheath tumors, including Schwannomas and Neurofibromas [3]. 3. **Langerhans Cell Histiocytosis (LCH):** Langerhans cells are dendritic cells that characteristically express S100, CD1a, and Langerin (CD207) [1]. This is a high-yield diagnostic triad for LCH [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Sensitivity vs. Specificity:** S100 is excellent for *ruling out* melanoma (high sensitivity), but because it stains many tissues, it cannot be used alone to *rule it in* (low specificity). * **Other S100 Positive Tissues:** Chondrocytes (Chondrosarcoma), Adipocytes (Liposarcoma), Myoepithelial cells (Salivary gland tumors), and Astrocytes (Gliomas). * **Memory Aid:** Think of S100 as the "Neural Crest Marker" to remember its association with Melanocytes, Schwann cells, and specialized dendritic cells. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 629-630. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 630. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, p. 1250.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free